Comparison of Different Propofol Formulations
Information source: Hopital Foch
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: General Anesthesia
Intervention: Propofol Astrazeneca plain (Drug); Propofol Astrazeneca plus lidocaine (Drug); Propofol-lipuro B. Braun plain (Drug); Propofol-lipuro B. Braun plus lidocaine (Drug); Propofol Fresenius plain (Drug); Propofol Fresenius plus lidocaine (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Hopital Foch Official(s) and/or principal investigator(s): Morgan LeGuen, MD, Principal Investigator, Affiliation: Hôpital Foch
Summary
The objective of this study is to evaluate the influence of different propofol
formulations(plain or with lidocaine)on anesthetic induction. Propofol plain or with
lidocaine is administered using a closed-loop algorithm in order to reach a Bispectral Index
target of 50.
Clinical Details
Official title: Dose-effect of Propofol for Anesthetic Induction: Double-blind Comparison of Different Propofol Formulations Administered Alone or With Lidocaine
Study design: Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: necessary dose of propofol to obtain the induction of anesthesia (defined by a bispectral index of 50)
Secondary outcome: calculated concentrations of propofol at the end of the anesthetic inductionmeasured plasma propofol concentrations at the end of anesthetic induction (in 20% of patients) pain at injection heart rate and arterial pressure modifications induced by anesthetic induction patients satisfaction necessary dose of propofol to obtain loss of consciousness calculated concentrations of propofol at loss of consciousness
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- patients scheduled for an intravenous induction of anesthesia with propofol
Exclusion Criteria:
- Age under 18
- Pregnancy or breastfeeding
- Allergy to propofol, soya or peanuts,
- Allergy to lidocaine,
- History of central neurological disorder or brain injury,
- Patients receiving psychotropic drugs,
- Patient with a pacemaker.
Locations and Contacts
Clinique Saint Augustin, Bordeaux 33000, France
Laboratoire de Pharmacologie Toxicologie, hôpital Raymond Poincaré, Garches 92380, France
Hôpital Foch, Suresnes 92151, France
Additional Information
Related publications: Liu N, Chazot T, Genty A, Landais A, Restoux A, McGee K, Laloë PA, Trillat B, Barvais L, Fischler M. Titration of propofol for anesthetic induction and maintenance guided by the bispectral index: closed-loop versus manual control: a prospective, randomized, multicenter study. Anesthesiology. 2006 Apr;104(4):686-95.
Starting date: December 2009
Last updated: July 18, 2011
|